| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |